## **Core Concept**
The treatment of severe and complicated falciparum malaria requires prompt and effective antimalarial therapy to prevent mortality and morbidity. The management involves the use of intravenous antimalarial drugs due to the severity of the condition and potential for gastrointestinal intolerance.

## **Why the Correct Answer is Right**
The correct answer, **Artesunate**, is recommended by the World Health Organization (WHO) and other international guidelines as the first-line treatment for severe and complicated Plasmodium falciparum malaria. Artesunate has been shown to reduce mortality compared to quinine. It works by generating reactive oxygen species that damage the proteins and membranes within the malaria parasite. Artesunate's rapid action and efficacy make it superior in treating severe malaria.

## **Why Each Wrong Option is Incorrect**
- **Option A: Chloroquine**. Chloroquine was once a mainstay in malaria treatment but is no longer effective for falciparum malaria in most parts of the world due to widespread resistance.
- **Option B: Quinine**. While quinine can be used for severe malaria, it is associated with more side effects and a higher risk of complications compared to artesunate. It is considered when artesunate is not available.
- **Option D: Mefloquine**. Mefloquine is used for chemoprophylaxis and treatment of uncomplicated malaria but not for severe and complicated cases due to its slower action and potential for neuropsychiatric side effects.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that artesunate is the drug of choice for severe malaria, and its use should be initiated as soon as possible. In areas where artesunate is not available, intravenous quinine is a recommended alternative. Always consider the local epidemiology of resistance when choosing an antimalarial.

## **Correct Answer:** . Artesunate